Longevity Medicine: Are NAD+ and Peptide Therapies Worth It? A Physician-Led Review

The pursuit of a longer, healthier life has moved from science fiction to clinical reality — but not every intervention marketed under the "longevity" umbrella is backed by equal evidence. As interest in longevity medicine surges among both patients and physicians, two therapies have emerged at the forefront of conversation: NAD+ supplementation and peptide therapy. In this physician-led review, we cut through the marketing noise to evaluate what the current science actually supports, what remains experimental, and how a structured, medically supervised approach can help you make smarter decisions about your health.

---

What Is Longevity Medicine, Really?

Longevity medicine — sometimes called healthspan medicine or anti-aging medicine — is a rapidly evolving field focused not just on extending lifespan, but on compressing morbidity: helping people stay healthier, more functional, and cognitively sharp for more of their years alive.

Unlike traditional disease-focused medicine, longevity protocols are proactive. They address the root biological mechanisms of aging, including:

Cellular senescence (the accumulation of damaged, non-dividing cells)

Mitochondrial dysfunction (declining energy production at the cellular level)

Chronic low-grade inflammation, often called "inflammaging"

Telomere attrition (shortening of protective chromosome caps)

Epigenetic dysregulation (changes in gene expression over time)

According to research published in Nature Medicine, the global burden of age-related diseases is accelerating, with chronic conditions like cardiovascular disease, type 2 diabetes, and neurodegeneration accounting for more than 70% of global deaths annually. Longevity medicine represents a paradigm shift — treating aging itself as a modifiable risk factor.

At iScript.care, Dr. Chomba Chuma, MD has built a physician-led, AI-powered platform that integrates these advanced protocols into accessible, personalized care pathways. Rather than one-size-fits-all supplements, iScript.care's approach begins with thorough assessment, biomarker testing, and evidence-based protocol matching.

---

NAD+ Therapy: The Science Behind the Hype

What Is NAD+ and Why Does It Decline?

Nicotinamide adenine dinucleotide (NAD+) is a coenzyme found in every living cell. It plays a central role in:

Energy metabolism — facilitating ATP production in the mitochondria

DNA repair — activating PARP enzymes that fix DNA strand breaks

Sirtuin activation — regulating sirtuins (SIRT1–SIRT7), proteins linked to cellular stress resistance and longevity

Circadian rhythm regulation — maintaining healthy sleep-wake cycles

The problem? NAD+ levels decline by approximately 50% between ages 40 and 60 according to multiple preclinical and clinical studies. This decline correlates with increased fatigue, cognitive slowing, metabolic dysfunction, and reduced cellular repair capacity.

How Is NAD+ Delivered?

There are several routes of administration used in clinical and functional medicine settings:

| Delivery Method | Bioavailability | Clinical Use Case | Typical Protocol |

|---|---|---|---|

| IV NAD+ Infusion | Very High (~100%) | Acute repletion, neurological recovery | 250–1000mg over 2–8 hours |

| Subcutaneous Injection | High | Ongoing maintenance, outpatient longevity | Daily or weekly dosing |

| NMN (Oral Precursor) | Moderate | Preventive maintenance, cost-effective | 250–1000mg/day orally |

| NR (Oral Precursor) | Moderate | Similar to NMN, slightly better studied | 300–1000mg/day orally |

| Nasal Spray / Topical | Low-Moderate | Cognitive focus, experimental | Variable |

What Does the Clinical Evidence Show?

NAD+ research has advanced significantly in the past decade, though many landmark studies have been in animal models. Here's an honest breakdown:

Promising clinical data:

A 2023 randomized controlled trial in Nature Aging showed that NMN supplementation in older adults improved muscle insulin sensitivity and physical function

Studies in older adults demonstrate that NR supplementation increases blood NAD+ levels by 40–90%

Early neurological research suggests potential benefit in conditions like Parkinson's disease, traumatic brain injury, and chronic fatigue syndrome

Where evidence is still limited:

Long-term outcome data (5+ years) in humans is largely absent

Most trials are small (under 100 participants)

Biomarker improvement does not always translate to clinical outcomes

FDA has not approved NAD+ therapy for any specific indication

Clinical Insight: "NAD+ is one of the most biologically compelling targets in aging science. The preclinical data is extraordinary — but I always tell my patients that we're practicing at the frontier. We use biomarker-guided dosing, not guesswork, and we monitor outcomes carefully." — Dr. Chomba Chuma, MD, Founder, iScript.care

---

Peptide Therapy: A Targeted Approach to Biological Optimization

What Are Therapeutic Peptides?

Peptides are short chains of amino acids — the building blocks of proteins — that act as biological messengers in the body. Unlike full proteins, peptides are small enough to be synthesized, studied, and administered therapeutically. They interact with specific receptors to modulate hormonal signaling, immune function, tissue repair, and metabolic pathways.

The field of peptide therapy review is wide-ranging. Clinically used and research-stage peptides include:

BPC-157 (Body Protective Compound): Derived from gastric juice proteins; studied for wound healing, tendon/ligament repair, gut health, and neuroprotection

Sermorelin / CJC-1295 / Ipamorelin: Growth hormone secretagogues that stimulate natural GH release — a more physiologic alternative to exogenous HGH

Thymosin Alpha-1 (Tα1): Immune modulator with clinical use in chronic infections and immune dysregulation (FDA-approved as Zadaxin in over 35 countries)

PT-141 (Bremelanotide): FDA-approved for hypoactive sexual desire disorder in women; used off-label in men

Epithalon: Pineal gland-derived; studied for telomere extension and circadian regulation

SS-31 (Elamipretide): Mitochondria-targeting peptide with cardiovascular and mitochondrial disease applications

Growth Hormone Secretagogues: The Most Clinically Relevant Peptides

Among longevity-focused physicians, GH secretagogues represent the most widely applied class of therapeutic peptides. Here's why:

Growth hormone levels decline by approximately 14% per decade after age 30

Low GH correlates with increased visceral fat, decreased lean muscle mass, reduced bone density, and cognitive changes

Secretagogues like CJC-1295 + Ipamorelin stimulate the pituitary's own GH release in a pulsatile, physiologic pattern — unlike direct HGH injections which can suppress endogenous production

Compared to exogenous HGH, secretagogue therapy typically offers:

Lower risk of side effects (less edema, less insulin resistance)

Preservation of natural feedback loop regulation

Lower cost and more accessible administration

---

Infographic Insight

Visual Concept: "The Longevity Toolkit — How NAD+ and Peptide Therapies Work in the Body"

>

This infographic should illustrate a human body silhouette with annotated pathways showing where and how longevity interventions act at the cellular and organ-system level. Include the following 6 key data points:

🔬 NAD+ Decline: NAD+ levels fall ~50% between ages 40–60, impairing mitochondrial function and DNA repair capacity

⚡ Energy Production: NAD+ is required for every step of the Krebs cycle; declining levels = declining cellular energy and resilience

🧬 Sirtuin Activation: NAD+ fuels SIRT1–SIRT7 enzymes, which regulate inflammation, stress response, and longevity gene expression

💉 Peptide Signaling: BPC-157 and similar peptides bind to specific tissue receptors to accelerate repair, reduce inflammation, and modulate the immune cascade

📈 GH Secretagogue Effect: CJC-1295 + Ipamorelin combinations restore youthful GH pulse patterns, improving body composition within 3–6 months

🩺 Physician-Led Monitoring: Biomarker tracking (IGF-1, NAD+ metabolomics, inflammatory markers, DEXA body composition) is essential to safe, effective longevity protocols

---

How These Therapies Fit Into a Comprehensive Longevity Protocol

The most important thing to understand about longevity protocols is that neither NAD+ nor peptide therapies work in isolation. The most effective, evidence-informed protocols layer multiple interventions:

The Foundational Stack

1. Diagnostic Baseline (Before Any Intervention)

Comprehensive metabolic panel, lipid panel with particle sizing

Hormonal panel (testosterone, estrogen, DHEA, cortisol, IGF-1, thyroid)

Inflammatory markers (hs-CRP, IL-6, fibrinogen)

Epigenetic age testing (e.g., Horvath clock methylation assays)

Microbiome assessment, nutrient status (NAD+ metabolomics, Vitamin D, B12, omega-3 index)

2. Lifestyle Optimization (Non-Negotiable)

Zone 2 aerobic training + resistance training (proven to upregulate mitochondrial biogenesis independently)

Sleep architecture optimization (7–9 hours; deep sleep critical for GH release)

Nutrition: low-glycemic, anti-inflammatory dietary patterns

Stress regulation: HRV biofeedback, mindfulness protocols

3. Metabolic Health Management

For patients with insulin resistance or prediabetes, metabolic optimization is essential before advanced therapies

iScript.care's GLP-1 program offers physician-supervised metabolic care that synergizes powerfully with longevity interventions — normalizing insulin sensitivity enhances both NAD+ metabolism and peptide receptor responsiveness

4. NAD+ and/or Peptide Protocols (Individualized)

Selected based on biomarker results, patient goals, and risk profile

Dosed and monitored by physicians, not based on influencer recommendations

5. Remote Patient Monitoring

Continuous or periodic data collection via wearables and connected devices

iScript.care's remote patient monitoring platform enables real-time biomarker tracking and physician oversight — critical for catching outliers and adjusting protocols safely

---

Who Is a Good Candidate for These Therapies?

Not everyone is an ideal candidate, and this is where physician-led assessment becomes indispensable.

Potential Candidates for NAD+ Therapy:

Adults over 40 with fatigue, cognitive fog, or metabolic decline

Patients recovering from chronic illness, long COVID, or substance use disorder

Athletes seeking enhanced recovery and performance optimization

Individuals with confirmed low NAD+ metabolomics on testing

Potential Candidates for Peptide Therapy:

Adults with confirmed low IGF-1 or growth hormone deficiency patterns

Patients with chronic musculoskeletal injuries or post-surgical recovery needs

Individuals with immune dysregulation or autoimmune conditions (Thymosin Alpha-1)

Men and women experiencing age-related body composition changes

Who Should NOT Pursue These Without Careful Screening:

Patients with active malignancy (GH secretagogues are contraindicated)

Patients with untreated thyroid dysfunction or pituitary pathology

Pregnant or breastfeeding individuals

Anyone with history of hormone-sensitive conditions without oncologist clearance

iScript.care's provider network includes board-certified physicians with expertise in functional and longevity medicine who conduct thorough pre-treatment assessments before recommending any protocol.

---

What Does Anti-Aging Telehealth Look Like in Practice?

The rise of anti-aging telehealth has democratized access to longevity medicine — but it has also created risks when platforms prioritize sales over safety. Here's what separates responsible telehealth-based longevity care from problematic direct-to-consumer programs:

| Feature | Evidence-Based Telehealth (iScript.care) | Unvetted DTC Platforms |

|---|---|---|

| Physician Oversight | Board-certified MD review of all protocols | Often absent or cursory |

| Baseline Biomarker Testing | Required before prescribing | Frequently skipped |

| Ongoing Monitoring | RPM-integrated, regular follow-up | Rare or automated only |

| Protocol Individualization | Tailored to labs, history, goals | Cookie-cutter packages |

| Regulatory Compliance | Full HIPAA, state licensing compliance | Variable |

| Patient Education | Physician-provided informed consent | Often marketing-driven |

Dr. Chomba Chuma, MD designed iScript.care's telehealth programs specifically to bridge this gap — providing concierge-level, physician-driven longevity care through an accessible, AI-enhanced digital platform. The platform's remote monitoring capabilities, powered by connected devices and sensors, allow continuous oversight that traditional clinic visits simply cannot match in frequency or resolution.

---

Safety Considerations and Regulatory Landscape

Transparency demands honesty about the regulatory status of these therapies:

NAD+ precursors (NMN, NR) are available as supplements in the US; IV NAD+ infusions are administered as compounded preparations through licensed compounding pharmacies under physician supervision

Most therapeutic peptides are prescribed as compounded medications — legal under FDA compounding guidelines but not individually FDA-approved (with exceptions like PT-141 and Thymosin Beta-4 derivatives)

The FDA's guidance on compounded drugs outlines the legal framework within which compounding pharmacies operate — and physician-prescribers carry responsibility for appropriate use

This is not a reason to avoid these therapies — it's a reason to pursue them only through qualified, accountable physicians. Research published in JAMA consistently demonstrates that supervised, protocol-driven care produces meaningfully better outcomes than self-directed supplementation, regardless of the intervention category.

Always discuss any longevity protocol with your physician, disclose all current medications (interactions with anticoagulants, immunosuppressants, and insulin sensitizers are clinically relevant), and ensure follow-up testing is built into the plan from day one.

---

Conclusion

Longevity medicine is no longer fringe — it is frontier medicine, and the evidence base for tools like NAD+ therapy and peptide protocols is growing rapidly. Neither should be dismissed as pseudoscience, nor embraced uncritically as cure-alls. The honest answer to "Are these therapies worth it?" is: it depends — on your biology, your goals, your baseline health, and critically, whether you have qualified physician oversight.

What we know with confidence:

NAD+ decline is real and measurable, and precursor supplementation demonstrably raises cellular NAD+ levels

Growth hormone secretagogues offer a physiologically sound approach to addressing age-related GH decline with a better safety profile than exogenous HGH

BPC-157, Thymosin Alpha-1, and other peptides have genuine mechanistic rationale and emerging clinical evidence — but require physician-guided selection and monitoring

No longevity intervention outperforms the fundamentals: sleep, movement, nutrition, and metabolic health remain the non-negotiable foundation

The difference between a transformative longevity protocol and an expensive, potentially harmful experiment is physician leadership, biomarker-guided decision-making, and continuous monitoring — exactly the model that iScript.care was built to deliver.

Have questions about longevity protocols, or want to understand which interventions might be appropriate for your biology and goals? Browse our resource library for more evidence-based content, or visit our FAQ to learn how iScript.care works.

---

Ready to take a physician-led approach to your longevity? Whether you're a patient seeking personalized care or a healthcare provider interested in integrating advanced protocols into your practice, the iScript.care team is here to help. Contact iScript.care today to speak with our clinical team, or start a free assessment to begin your personalized longevity protocol journey — backed by board-certified physicians, AI-powered monitoring, and a genuine commitment to your healthspan.

---

Reviewed and authored by Dr. Chomba Chuma, MD, Founder of iScript.care. This article is intended for educational purposes and does not constitute individualized medical advice. Always consult a qualified physician before beginning any new medical protocol.